Clinical Trial Update: Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposomal paclitaxel plus nedaplatin in advanced or recurrent esophageal cancer has completed, with the update indicating stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Nedaplatin (nedaplatin)
• liposomal paclitaxel (liposomal paclitaxel)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Carcinoma | Phase 2 | Status: COMPLETED